Parameter
| Biomarker | STK25 | Full name | Serine/Threonine Kinase 25 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis, risk stratification | ||
| Disease | Acute Myeloid Leukemia (AML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Bone marrow (RNA sequencing, siRNA validation) | ||
| Pathobiological Mechanisms | High expression promotes AML cell survival, while knockdown inhibits proliferation. | ||||
| Clinical Availability Status | Research Verification: Incorporating a novel risk stratification system. | ||||
| Notes and Dynamics | Provide new molecular basis for precise prognosis assessment of AML. | ||||